Johnson & Johnson
Search results
Our iconic brands have a new home where thoughtful everyday care meets scientific precision. As a global consumer health leader, Kenvue touches the lives of more than a billion people across the globe.
Jul 31, 2023 · If you’ve heard of Kenvue, you may already know that we’re a global consumer health company. But beyond our portfolio of iconic brands, Kenvue is built on a foundation of core values, which fuel our 22,000+ global team members every day. Here’s what you need to know: 1. You already know us
Sep 28, 2022 · Kenvue Post-Separation: A Leading Global Consumer Health Company with Iconic Brands and Commitment to Continued Innovation. Kenvue will become a standalone leading global consumer health company in 2023, subject to legal requirements including consultation with works councils and employee representatives, as required.
Aug 23, 2023 · SKILLMAN, N.J. August 23, 2023 – Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced its separation from Johnson & Johnson, marking its first day as a fully independent company.
Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage and propelled forward by science, our iconic brands — including Aveeno ...
Sep 28, 2022 · Kenvue Post-Separation: A Leading Global Consumer Health Company with Iconic Brands and Commitment to Continued Innovation
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Mylanta, Neutrogena, Trosyd, Tylenol, and Visine.
Empowered healthcare starts with you. That’s what we believe at Kenvue. We’re the same iconic brands you know and can trust, backed by more than 135 years of research and development, now housed under a dedicated umbrella of continuous innovation.
May 3, 2023 · J&J's consumer health spinoff, Kenvue, is expected to set an initial public offering price Wednesday night and trade Thursday on the New York Stock Exchange.
2 days ago · With $15.4 billion in net sales in 2023, we are the world’s largest pure-play consumer health company by revenue and hold a unique position at the intersection of healthcare and consumer goods.
